Master in Biotechnology for Innovative Therapeutics

Biotechnology for Innovative Therapeutics sits at the intersection of biology, medicine, and applied science, focusing on how biological knowledge is translated into new treatments and therapies. Students in this field typically study molecular biology, genetics, pharmacology, and the biological mechanisms underlying disease, alongside the methods used to develop and test new therapeutic approaches, including biologics, gene-based therapies, and other advanced treatment technologies. Laboratory work is generally central to programs in this area, giving students direct experience with the techniques used in biomedical research, from molecular analysis to the evaluation of how potential therapies behave in biological systems. Coursework also often covers the broader process of drug and therapy development, including how new treatments move from early research through to clinical application, giving students insight into both the science and the practical pathway of therapeutic innovation. As biotechnology continues to drive advances in medicine, graduates in this field find opportunities in pharmaceutical and biotechnology companies, research institutions, and healthcare organizations, working as research scientists, laboratory specialists, or in roles that bridge scientific research and product development. This master's degree in Biotechnology for Innovative Therapeutics is offered by UNISR - Università Vita Salute San Raffaele in Milano, Italy, and is taught in English over two years. Admission is by entrance examination, and applicants are expected to hold a bachelor's degree or equivalent. Graduates leave with the specialized scientific training needed to contribute to the research and development of new therapeutic approaches within the biotechnology and pharmaceutical sectors.